• Contact/
  • Home/

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • Advent Life Sciences
  • Advent Life Sciences

Page 1 of 16

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10Next >End >>
22.12.2017Aura Biosciences Completes $30 Million Series C Financing

Press Release

26.10.2017Acutus Medical® Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias

 

Press Release

28.09.2017NeRRe Therapeutics appoints Andrew Kay as Chairman of the Board

 

Press Release

27.09.2017KaNDy Therapeutics launched to advance a breakthrough treatment in Women's Health

 

Press Release

10.05.2017Iterum Secures $65 Million in Series B Financing

Press Release

03.05.2017Axonics Announces $14.5 Million First Close of Series C Financing

Press Release

16.03.2017Moximed Closes Oversubscribed $50MM Financing Round

Press Release

27.02.2017Arrakis Therapeutics Announces $38M Series A Financing To Target RNA with Small-Molecule Medicines And Names Michael Gilman Chairman and CEO

Press Release

05.01.2017NeRRe Therapeutics raises £23 million in oversubscribed Series B financing round

Press Release

29.09.2016Aura Biosciences Secures $8 Million in Additional Funding

Press Release



  • Legal and Regulatory Matters

©2018 Advent Life Sciences